Brain neurotrophic supply in ontogenesis and during development of neurodegenerative diseases

[1]  A. Nairn.  Faculty of 1000 evaluation for GDNF, NGF and BDNF as therapeutic options for neurodegeneration. , 2016 .

[2]  M. Bothwell,et al.  Open Peer Review Recent Advances in Understanding Neurotrophin Signaling [version 1; Referees: 2 Approved] , 2022 .

[3]  E. Gasanov,et al.  Neurotrophin Propeptides: Biological Functions and Molecular Mechanisms. , 2016, Current protein & peptide science.

[4]  N. Stefanova,et al.  Evolution of Alzheimer’s disease pathogenesis conception , 2016, Moscow University Biological Sciences Bulletin.

[5]  N. Stefanova,et al.  Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease‐like pathology , 2015, Journal of pineal research.

[6]  J. Armendáriz-Borunda,et al.  Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson’s disease , 2015, Journal of Biomedical Science.

[7]  R. Leis,et al.  Hypothalamic-autonomic control of energy homeostasis , 2015, Endocrine.

[8]  J. Stern.  Neuroendocrine‐Autonomic Integration in the Paraventricular Nucleus: Novel Roles for Dendritically Released Neuropeptides , 2015, Journal of neuroendocrinology.

[9]  L. Yanshole,et al.  Beneficial effects of melatonin in a rat model of sporadic Alzheimer’s disease , 2015, Biogerontology.

[10]  Kimberly S. Williams,et al.  The p75 neurotrophin receptor: at the crossroad of neural repair and death , 2015, Neural regeneration research.

[11]  Masayuki Miura,et al.  Programmed cell death in neurodevelopment. , 2015, Developmental cell.

[12]  M. Bannon,et al.  The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson’s Disease , 2015, PloS one.

[13]  J. Yang,et al.  Profiling the circulating miRNAs in mice exposed to gram-positive and gram-negative bacteria by Illumina small RNA deep sequencing , 2015, Journal of Biomedical Science.

[14]  J. Morley,et al.  The role of amyloid-beta in the regulation of memory. , 2014, Biochemical pharmacology.

[15]  T. Outeiro,et al.  Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease , 2014, Drugs & Aging.

[16]  Ivanov Ad.  The role of NGF and BDNF in mature brain activity regulation , 2014 .

[17]  N. Karpova.  Role of BDNF epigenetics in activity-dependent neuronal plasticity , 2014, Neuropharmacology.

[18]  E. Smith,et al.  Nerve growth factor and nociception: from experimental embryology to new analgesic therapy. , 2014, Handbook of experimental pharmacology.

[19]  Y. Barde,et al.  Death of developing neurons: New insights and implications for connectivity , 2013, The Journal of cell biology.

[20]  Meharvan Singh,et al.  Progesterone, brain-derived neurotrophic factor and neuroprotection , 2013, Neuroscience.

[21]  R. Handa,et al.  Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor , 2013, Neuroscience.

[22]  N. Patel,et al.  GDNF, NGF and BDNF as therapeutic options for neurodegeneration. , 2013, Pharmacology & therapeutics.

[23]  S. Endo,et al.  Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes , 2013, BMC Genomics.

[24]  S. Mi,et al.  A DR6/p75NTR complex is responsible for β-amyloid-induced cortical neuron death , 2013, Cell Death and Disease.

[25]  P. Casey,et al.  Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases , 2013, Cell Death and Disease.

[26]  Satoru Miyazaki,et al.  Two-way AIC: detection of differentially expressed genes from large scale microarray meta-dataset , 2013, BMC Genomics.

[27]  A. Schally,et al.  Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease , 2012, Aging.

[28]  E. Castrén,et al.  Mapping of the Interaction Site between Sortilin and the p75 Neurotrophin Receptor Reveals a Regulatory Role for the Sortilin Intracellular Domain in p75 Neurotrophin Receptor Shedding and Apoptosis* , 2012, The Journal of Biological Chemistry.

[29]  J. Hancock,et al.  The Effects of Transmembrane Sequence and Dimerization on Cleavage of the p75 Neurotrophin Receptor by γ-Secretase* , 2012, The Journal of Biological Chemistry.

[30]  J. Newcombe,et al.  Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration , 2012, The Journal of experimental medicine.

[31]  Jing Liang,et al.  Roles of BDNF, dopamine D3 receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitization , 2011, European Neuropsychopharmacology.

[32]  X. Tong,et al.  Ligand-Dependent TrkA Activity in Brain Differentially Affects Spatial Learning and Long-Term Memory , 2011, Molecular Pharmacology.

[33]  A. Contestabile.  The history of the cholinergic hypothesis , 2011, Behavioural Brain Research.

[34]  C. Billington,et al.  The lighter side of BDNF. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  A. Thomson,et al.  Positive Feedback Regulation between γ-Aminobutyric Acid Type A (GABAA) Receptor Signaling and Brain-derived Neurotrophic Factor (BDNF) Release in Developing Neurons* , 2011, The Journal of Biological Chemistry.

[36]  B. Diniz,et al.  Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. , 2010, Biomarkers in medicine.

[37]  Y. Barde,et al.  Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not , 2010, Nature.

[38]  A. Cattaneo,et al.  Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration , 2010, Proceedings of the National Academy of Sciences.

[39]  A. Teixeira,et al.  Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease , 2010, Journal of Neurology.

[40]  M. Constantine‐Paton,et al.  Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease , 2010, Developmental neurobiology.

[41]  S. Paul,et al.  Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression , 2009, The Journal of Neuroscience.

[42]  N. Schor,et al.  Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor , 2009, Oxidative medicine and cellular longevity.

[43]  H. Jacobsen,et al.  Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.

[44]  Z. Salehi,et al.  Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson’s disease , 2009, Journal of Clinical Neuroscience.

[45]  J. Bolam,et al.  The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's disease. , 2008, CNS & neurological disorders drug targets.

[46]  L. Puglielli,et al.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit? , 2008, Neurobiology of Aging.

[47]  B. Fox,et al.  β-Amyloid1–42 Induces Neuronal Death through the p75 Neurotrophin Receptor , 2008, The Journal of Neuroscience.

[48]  Jing Zhang,et al.  CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. , 2008, American journal of clinical pathology.

[49]  M. MacDonald,et al.  RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease , 2007, Brain pathology.

[50]  A. Levine,et al.  Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[51]  A. Cuello,et al.  NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. , 2007, Current Alzheimer research.

[52]  F. Khuri,et al.  Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. , 2007, Cancer research.

[53]  R. Balice-Gordon,et al.  Localization of TrkC to Schwann cells and effects of neurotrophin‐3 signaling at neuromuscular synapses , 2007, The Journal of comparative neurology.

[54]  M. Tuszynski,et al.  Estradiol‐induced modulation of estrogen receptor‐β and GABA within the adult neocortex: A potential transsynaptic mechanism for estrogen modulation of BDNF , 2006, The Journal of comparative neurology.

[55]  K. Terao,et al.  Amyloid β up‐regulates brain‐derived neurotrophic factor production from astrocytes: Rescue from amyloid β‐related neuritic degeneration , 2006 .

[56]  B. Jasmin,et al.  BDNF Is Expressed in Skeletal Muscle Satellite Cells and Inhibits Myogenic Differentiation , 2006, The Journal of Neuroscience.

[57]  J. Lucas,et al.  Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain , 2006, The European journal of neuroscience.

[58]  P. Bickford,et al.  Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta , 2005, The Journal of Neuroscience.

[59]  M. Chao,et al.  Cleavage of p75 Neurotrophin Receptor by α-Secretase and γ-Secretase Requires Specific Receptor Domains* , 2005, Journal of Biological Chemistry.

[60]  M. Ahmadian,et al.  Inactivation and activation of Ras by the neurotrophin receptor p75 , 2004, The European journal of neuroscience.

[61]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[62]  M. Staufenbiel,et al.  Induction of Brain-derived Neurotrophic Factor in Plaque- Associated Glial Cells of Aged App23 Transgenic Mice , 2022 .

[63]  Barbara L. Hempstead,et al.  Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.

[64]  P. Follesa,et al.  High affinity neurotrophin receptors in the human pre-term newborn, infant, and adult cerebellum , 2003, International Journal of Developmental Neuroscience.

[65]  M. Poo,et al.  Brain-Derived Neurotrophic Factor Modulation of GABAergic Synapses by Postsynaptic Regulation of Chloride Transport , 2003, The Journal of Neuroscience.

[66]  E. H. Goulding,et al.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor , 2003, Nature Neuroscience.

[67]  S. Fahn.  Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.

[68]  Y. Barde,et al.  The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system , 2002, Nature Neuroscience.

[69]  G. Perini,et al.  Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory Cytokines , 2002, The Journal of experimental medicine.

[70]  R. Stephens,et al.  The Cytoplasmic and Transmembrane Domains of the p75 and Trk A Receptors Regulate High Affinity Binding to Nerve Growth Factor* , 2001, The Journal of Biological Chemistry.

[71]  P. Sokoloff,et al.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization , 2001, Nature.

[72]  T. Roskams,et al.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors , 2001, Hepatology.

[73]  G. Donnan,et al.  Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra , 2000, Experimental Neurology.

[74]  A. Represa,et al.  Spatiotemporal expression of noncatalytic TrkC NC2 isoform during early and late CNS neurogenesis: a comparative study with TrkC catalytic and p75NTR receptors , 2000, The European journal of neuroscience.

[75]  M. Yamada,et al.  Regulation of reactive oxygen species by nerve growth factor but not Bcl-2 as a novel mechanism of protection of PC12 cells from superoxide anion-induced death. , 1999, Journal of biochemistry.

[76]  P. Barker,et al.  Transgenic Mice Expressing the Intracellular Domain of the p75 Neurotrophin Receptor Undergo Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[77]  Brock L. Eide,et al.  Naturally Occurring Truncated trkB Receptors Have Dominant Inhibitory Effects on Brain-Derived Neurotrophic Factor Signaling , 1996, The Journal of Neuroscience.

[78]  S. Cohen,et al.  A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SNAKE VENOM. , 1956, Proceedings of the National Academy of Sciences of the United States of America.

[79]  V. Hamburger,et al.  A diffusible agent of mouse sarcoma, producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryo , 1953 .

[80]  H. Gonzalo,et al.  Oxidative stress and neurodegenerative diseases: a neurotrophic approach. , 2015, Current drug targets.

[81]  B. Lu,et al.  BDNF and synaptic plasticity, cognitive function, and dysfunction. , 2014, Handbook of experimental pharmacology.

[82]  N. Unsain,et al.  Neurotrophins in the regulation of cellular survival and death. , 2014, Handbook of experimental pharmacology.

[83]  B. Carter,et al.  The biological functions and signaling mechanisms of the p75 neurotrophin receptor. , 2014, Handbook of experimental pharmacology.

[84]  M. Bothwell.  NGF, BDNF, NT3, and NT4. , 2014, Handbook of experimental pharmacology.

[85]  B. Hempstead.  Deciphering proneurotrophin actions. , 2014, Handbook of experimental pharmacology.

[86]  P. Carroll,et al.  Neurotrophin signalling and transcription programmes interactions in the development of somatosensory neurons. , 2014, Handbook of experimental pharmacology.

[87]  E. Cattaneo,et al.  Huntington's disease. , 2014, Handbook of experimental pharmacology.

[88]  O. M. Lazo,et al.  Spatiotemporal intracellular dynamics of neurotrophin and its receptors. Implications for neurotrophin signaling and neuronal function. , 2014, Handbook of experimental pharmacology.

[89]  M. Rios.  Neurotrophins and the regulation of energy balance and body weight. , 2014, Handbook of experimental pharmacology.

[90]  R. Bakay,et al.  Neurotrophic factor therapy for Parkinson's disease. , 2010, Progress in brain research.

[91]  G. Riedel,et al.  Cytoskeletal Transport in the Aging Brain: Focus on the Cholinergic System , 2006, Reviews in the neurosciences.

[92]  K. Terao,et al.  Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration. , 2006, Journal of neuroscience research.

[93]  M. Chao,et al.  Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. , 2005, The Journal of biological chemistry.

[94]  D. Sampath,et al.  Regulation of Antioxidant Enzyme Expression by NGF , 2004, Neurochemical Research.

[95]  V. Desmet,et al.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. , 2001, Hepatology.

[96]  V. Frolkis,et al.  Aging of the Brain , 1982 .